Valuation: Seer, Inc.

Market Cap 119M 103M 96.35M 87.91M 165M 11.33B 168M 1.13B 443M 5.67B 446M 436M 18.91B P/E 2026 *
-2.07x
P/E 2027 * -2.2x
Enterprise Value 119M 103M 96.35M 87.91M 165M 11.33B 168M 1.13B 443M 5.67B 446M 436M 18.91B EV / Sales 2026 *
7.31x
EV / Sales 2027 * 5.67x
Free-Float
85.46%
Yield 2026 *
-
Yield 2027 * -
1 week-2.26%
Current month-2.70%
1 month-0.46%
3 months+18.03%
6 months+13.09%
Current year+18.03%
1 week 2.14
Extreme 2.145
2.22
1 month 1.82
Extreme 1.82
2.25
Current year 1.55
Extreme 1.55
2.34
1 year 1.55
Extreme 1.55
2.41
3 years 1.46
Extreme 1.455
2.88
5 years 1.46
Extreme 1.455
45.85
10 years 1.46
Extreme 1.455
86.55
Manager TitleAgeSince
Chief Executive Officer 57 01/03/2018
Director of Finance/CFO 58 01/05/2020
Chief Operating Officer - -
Director TitleAgeSince
Chairman 57 01/09/2020
Director/Board Member 76 01/12/2017
Director/Board Member 70 01/12/2017
Date Insider Type Main position Quantity % Market Cap.
28/07/26 Free

Director

41,500 0.0750%
28/07/26 Free

Director

41,500 0.0750%
28/07/26 Free

Director

31,125 0.0563%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.26%-2.26%-21.45% 119M
+0.68%+0.01%+14.38%+15.92% 28.6B
+1.25%+2.97%+21.51%-3.78% 7.51B
-10.30%-6.07%+16.30%-46.77% 3.13B
-2.13%+28.26%+15.18%+93.93% 3.07B
+1.23%+3.13%+91.59%+79.63% 2.58B
+4.26%+32.98%+118.12%+121.79% 1.79B
-1.48%+13.99%+16.16%+16.07% 1.7B
+5.19%+20.38%+11.83%+57.50% 1.32B
-1.18%+4.58%-37.99%-26.83% 835M
Average -0.12%+1,423.26%+26.48%+28.60% 5.06B
Weighted average by Cap. +0.16%+1,860.68%+22.28%+21.12%

Financials

2026 *2027 *
Net sales 16.25M 14.08M 13.18M 12.03M 22.64M 1.55B 23.02M 155M 60.57M 776M 61.01M 59.68M 2.59B 20.95M 18.16M 17M 15.51M 29.18M 2B 29.67M 199M 78.08M 1B 78.66M 76.95M 3.34B
Net income -58.65M -50.83M -47.58M -43.42M -81.7M -5.59B -83.07M -558M -219M -2.8B -220M -215M -9.34B -55.7M -48.27M -45.19M -41.23M -77.59M -5.31B -78.89M -530M -208M -2.66B -209M -205M -8.87B
Net Debt - -
Logo Seer, Inc.
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Employees
124
Date Price Change Volume
12/08/26 $2.160 0.00% 197,491
10/08/26 $2.160 -0.46% 150,883
07/08/26 $2.170 -0.91% 268,261
06/08/26 $2.190 0.00% 381,376
05/08/26 $2.190 -0.90% 155,614
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.160USD
Average target price
4.000USD
Spread / Average Target
+85.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEER Stock